What did Merit Medical pay for BioLife?

Merit Medical acquired BioLife for $120.0M in 2025, equivalent to 8.00x revenue. Target revenue was approximately $15.0M.

What does BioLife do?

BioLife is a medical devices business.

What multiple did Merit Medical pay for BioLife?

8.00x revenue, based on disclosed deal value of $120.0M and disclosed financials.

M&A TRANSACTION · 2025

BioLife acquired by Merit Medical

$120.0M· 8.00x revenue

Target

BioLife

Acquirer

Merit Medical

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$15.0M

EBITDA

—

Deal Value

$120.0M

EV/EBITDA

—

Context

This $120.0M acquisition of BioLife by Merit Medical sits in the medical devices sub-vertical. Merit Medical is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the BioLife acquisition.

Citation: ExitValue.ai. (2025). BioLife acquired by Merit Medical. https://exitvalue.ai/deals/biolife-acquired-by-merit-medical-hc-2025-0011